We present a case of clear cell renal cell carcinoma, which demonstrates complementary FDG and prostate-specific membrane antigen (PSMA) uptake on metastases in PET/CT, as an example of tumor heterogeneity. The patient had non-FDG-avid lung and bone metastases with PSMA uptake, whereas metastatic cervical and axillary lymph nodes showed vice versa, and skeletal muscle metastasis to vastus lateralis, which is an unusual region for metastasis, showed both PSMA and FDG positivity. In response assessment, mix response was detected. It seems that 68Ga-PSMA and 18F-FDG may have a complementary role in demonstration of metastasis accurately and assessment of treatment response in clear cell renal cell carcinom
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal malignancy in adults.1 T...
Peritoneal metastasis of prostate cancer (PC) is unusual site of metastatic disease; only limited ca...
A 76-year-old man with biochemical failure after primary radiotherapy for prostate cancer had no mal...
Renal cell carcinoma (RCC) shows variable FDG uptake; recently, PET/CT with prostate-specific membra...
Purpose To evaluate the diagnostic potential of whole-bodyPET/CT using a 68Ga-labelled PSMA ligand i...
PET/CT with prostate-specific membrane antigen (PSMA)-targeted tracers has been used in the diagnosi...
Metastatic renal cell carcinoma (mRCC) is a disease that portends poor prognosis despite an increasi...
Background: In this study, we prospectively evaluate the diagnostic potential of a gallium-68 (68Ga)...
Metastatic renal cell carcinoma (mRCC) is a disease that portends poor prognosis despite an increasi...
To critically review the potential clinical applications of prostate-specific membrane antigen (PSMA...
BACKGROUND: Recent articles proposed the employment of positron emission tomography/computed tomogra...
Background: Renal masses detection is continually increasing worldwide, with Renal Cell Carcinoma (R...
Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission tomography...
Purpose: The role of Ga-PSMA PET/CT in the staging of prostate cancer is well known. PSMA is also ov...
Positron emission tomography combined with computed tomography (PET/CT) is a method, capable of eval...
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal malignancy in adults.1 T...
Peritoneal metastasis of prostate cancer (PC) is unusual site of metastatic disease; only limited ca...
A 76-year-old man with biochemical failure after primary radiotherapy for prostate cancer had no mal...
Renal cell carcinoma (RCC) shows variable FDG uptake; recently, PET/CT with prostate-specific membra...
Purpose To evaluate the diagnostic potential of whole-bodyPET/CT using a 68Ga-labelled PSMA ligand i...
PET/CT with prostate-specific membrane antigen (PSMA)-targeted tracers has been used in the diagnosi...
Metastatic renal cell carcinoma (mRCC) is a disease that portends poor prognosis despite an increasi...
Background: In this study, we prospectively evaluate the diagnostic potential of a gallium-68 (68Ga)...
Metastatic renal cell carcinoma (mRCC) is a disease that portends poor prognosis despite an increasi...
To critically review the potential clinical applications of prostate-specific membrane antigen (PSMA...
BACKGROUND: Recent articles proposed the employment of positron emission tomography/computed tomogra...
Background: Renal masses detection is continually increasing worldwide, with Renal Cell Carcinoma (R...
Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission tomography...
Purpose: The role of Ga-PSMA PET/CT in the staging of prostate cancer is well known. PSMA is also ov...
Positron emission tomography combined with computed tomography (PET/CT) is a method, capable of eval...
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal malignancy in adults.1 T...
Peritoneal metastasis of prostate cancer (PC) is unusual site of metastatic disease; only limited ca...
A 76-year-old man with biochemical failure after primary radiotherapy for prostate cancer had no mal...